Quick Facts: Primary Uses (Requires Prescriber Guidance)

• Relief of Signs and Symptoms: Helps manage discomfort associated with certain forms of arthritis.
• Targeted Conditions: Appropriate for the therapeutic management of rheumatoid arthritis and osteoarthritis.
• Inflammatory Support: Used to address the signs and symptoms of ankylosing spondylitis.

---

What Voltaren 12,5 Treats: Main Uses and Benefits

Voltaren 12,5 (diclofenac sodium) is an established therapeutic option utilized for the relief of the signs and symptoms associated with specific inflammatory conditions. This medication is indicated for the management of chronic conditions such as rheumatoid arthritis and osteoarthritis, which involve joint inflammation and discomfort. It is also used in the relief of symptoms related to ankylosing spondylitis, a type of arthritis that primarily affects the spine.

By following its established pharmacological actions, this medication helps to improve patient comfort and supports functional capacity. It is used as a component of a comprehensive treatment plan, but it does not represent a cure for these long-term conditions. The appropriate use and duration of therapy should be determined by a healthcare provider, consistent with individual patient treatment goals. This drug is intended for use under the supervision of a physician to manage the indicated symptoms.

Voltaren 12,5 mg (diclofenac) suppository is approved for systemic use in children aged 1 year or over and adolescents, with the 12.5 mg strength specifically suited for those below 14 years of age. Use in adults is also allowed. Use is contraindicated in children under 12 months of age.

Eligibility Status	Excluded Populations (Selected)
Absolute Contraindication	Active GI ulcer/bleeding, severe hepatic or renal failure, established congestive heart failure (NYHA II-IV), ischemic heart disease, or other vascular diseases.
Absolute Contraindication	Patients with hypersensitivity to NSAIDs or those experiencing NSAID-induced asthma, and women in the last trimester of pregnancy.

Use is not recommended for women who are breastfeeding or attempting to conceive. Caution is required for populations with mild-to-moderate renal or hepatic impairment, as well as for those with risk factors for cardiovascular events such as hypertension or diabetes. The medicine is also contraindicated in patients with proctitis due to the administration route.

Interactions with other medicines and products

This section outlines the formally documented interaction patterns of the active ingredient, Diclofenac, as established in government regulatory sources. These interactions are categorized by their official mechanism and resulting constraints.

---

Pharmacodynamic and Contraindicated Combinations

Category	Official Interaction Constraint
Surgical Setting	Contraindicated in the peri-operative setting of Coronary Artery Bypass Graft (CABG) surgery.
Other NSAIDs / Aspirin	Not generally recommended for co-administration due to an increased risk of serious gastrointestinal events.
Anticoagulants / SSRIs	Co-administration is associated with an officially documented increased risk of serious bleeding.
ACE Inhibitors / Diuretics	May diminish the antihypertensive or natriuretic efficacy of these medications.

---

Pharmacokinetic and Substance Interactions

Category	Official Interaction Outcome
Exposure-Modifying Drugs	Increases the serum concentration and prolongs the half-life of substances such as Digoxin and Lithium.
Metabolic Inhibitors	Co-administration with strong inhibitors of the CYP2C9 enzyme (e.g., Voriconazole) results in a substantial increase in Diclofenac exposure (Cmax and AUC).
Substance Interaction	Ingestion of Alcohol is documented to increase the risk of gastric irritation and gastrointestinal mucosal bleeding.

---

Population-Specific Note: The risk of deterioration of renal function with co-administration of ACE Inhibitors, ARBs, or Diuretics is specifically noted to be heightened in elderly or volume-depleted patients.

How Voltaren 12,5 Works — Mechanism of Action

---

The mechanism of action for Diclofenac involves acting as a non-selective inhibitor of the Cyclooxygenase (COX) enzymes, targeting both the constitutive COX-1 and inducible COX-2 isoforms. This molecular interaction reversibly blocks the enzymatic conversion of arachidonic acid into prostaglandins (PGE2) and related eicosanoids .

This reduction in PGE2 synthesis engages multiple physiological domains. Peripherally, the lowered prostaglandin levels decrease nociceptor excitability and reduce prostaglandin-mediated vascular responses, including vasodilation and increased capillary permeability. Centrally, the inhibition of PGE2 production within the hypothalamus facilitates the resetting of the thermal set-point. This change subsequently engages the body's heat-dissipation mechanisms, modulating the elevated core temperature control.

Administration Guidelines for Voltaren 12,5

The administration of Voltaren 12.5 mg (Diclofenac Sodium) is for rectal use; it is not for oral intake. This low-strength preparation is designated as generally suitable for children aged 1 year and over, though its use is restricted for children under 1 year of age.

---

Dosage Calculation and Frequency

The standard daily dosage is not fixed but is calculated based on body weight for the pediatric population, typically ranging from 0.5 to 2 mg/kg. This total daily amount is divided into two or three separate administrations throughout the day. For specific management of Juvenile Rheumatoid Arthritis, the total daily dosage may be raised up to a maximum of 3 mg/kg. A strict absolute maximum of 150 mg of diclofenac, encompassing all administered forms, must not be exceeded in a single day.

---

Procedural Conditions and Duration

For proper systemic delivery and absorption, the suppository is administered well into the rectum, ideally after the bowels have been emptied. The patient should then avoid a bowel movement for at least one hour following insertion. The duration of therapy follows the principle of using the lowest effective dose for the shortest possible time, with long-term use (exceeding four weeks) necessitating periodic clinical re-evaluation. Adult use of this strength is also documented as a supplementary single dose, typically administered at bedtime, to control symptoms persisting overnight.

Research evidence / Overview of studies for Voltaren 12,5

---

Evidence for Use in Chronic Inflammatory Conditions

Research has explored the drug class in the context of conditions such as rheumatoid arthritis and osteoarthritis. The evidence base includes many Randomized Controlled Trials (RCTs) and systematic reviews that have examined how symptoms change over time in adult populations, measuring outcomes related to physical discomfort and functional capacity. Studies have reported how symptoms evolved and show patterns related to physical discomfort measured in trials involving this class of medicine. However, evidence for the specific rectal suppository form for long-term management is limited, as data are often an extrapolation from oral formulations, and long-term effects are not fully established.

---

Evidence for Use in Acute Pain Management (Pediatrics)

The evidence for using this medicine in acute settings comes primarily from short-term RCTs and systematic reviews focused on pediatric populations following surgery. These studies explored outcomes describing episodic or acute changes, such as measuring the time to need for rescue pain medication and changes in pain intensity scores. Trials measured these outcomes, and findings described certain patterns in this measurement compared to placebo. A consistent limitation is that follow-up durations were limited to the immediate post-operative period. Data remain insufficient concerning the evidence for appropriate use patterns in acute pediatric care and the lack of comprehensive data on outcomes in children with certain comorbidities.

---

What Is Still Uncertain About Voltaren 12,5 Studies

The overall research indicates that certainty remains low in several areas. Comparative evidence is lacking in some subgroups, and the long-term characterization of the specific rectal suppository for chronic conditions is an extrapolation from other routes of administration. It is important to note that available research does not determine whether an individual will respond similarly to the patterns observed in trials, as findings describe group patterns, not personal outcomes.

Common questions about Voltaren 12,5 (FAQ)

Q: Is Voltaren 12,5 the same medication as prescription-strength Voltaren?

The active ingredient in this medicine is diclofenac sodium, which is the same core ingredient found in all strengths of Voltaren products. However, the 12.5 mg strength is a distinct, low-dose formulation. Official documents indicate it is primarily used for the pediatric population or as a supplementary dose for adults.

Q: What is the difference between Voltaren 12,5 and diclofenac potassium?

Voltaren 12.5 mg suppositories contain the active ingredient formulated as the diclofenac sodium salt. Diclofenac can be manufactured using different chemical salts, such as sodium or potassium. This product uses the sodium salt.

Q: How frequently do people experience serious side effects when taking Voltaren 12,5?

According to official safety profiles, serious adverse reactions are generally listed within the Rare or Very Rare frequency categories. For instance, severe reactions involving the cardiovascular system or the skin are reported very rarely. This means they affect only a small number of people who use the medicine.

Q: How does Voltaren 12,5 potentially affect kidney function?

Official documents state that diclofenac, like other medicines in its class, can cause fluid retention and oedema (swelling). Regulatory warnings indicate that caution may be necessary when this medicine is administered to patients who have pre-existing impaired renal (kidney) function. Kidney damage is noted as a potential adverse event.

Q: Does Voltaren 12,5 typically cause drowsiness or impact the ability to drive?

Side effects involving the nervous system, such as dizziness, drowsiness, or fatigue, are reported in the official product information. If such effects occur, official product information advises that the patient should avoid driving or operating machinery.

Q: Are there any reports suggesting Voltaren 12,5 can cause changes in blood pressure?

Hypertension (high blood pressure) is listed as an uncommon or very rare adverse reaction associated with diclofenac in the official safety documents.

Q: Does taking Voltaren 12,5 affect the results of certain medical tests?

Official product information notes that taking diclofenac may cause an increase in liver enzyme values and has also been associated with changes in blood cell counts. These factors are assessed when running certain routine laboratory tests.

Q: What is the role of the 12,5 mg dose in managing inflammatory conditions?

The 12.5 mg strength is primarily recommended for use in the pediatric population, specifically children aged 1 year and over and adolescents below 14 years of age. Its use in these age groups is determined by body weight-based calculations.

Q: Is Voltaren 12,5 effective for treating migraine or tension headaches?

Official therapeutic indications state that this medicine is intended for the treatment of migraine attacks. The medicine is not typically indicated for general tension headaches.

Q: Why does Voltaren 12,5 sometimes seem like it is not working?

Official documents note that a patient's need for symptomatic relief and their response to therapy should be reevaluated periodically. This acknowledges that individual response can vary. If symptoms persist or do not improve, reevaluation by a healthcare provider is generally necessary.

Q: What signs might indicate an allergic reaction to Voltaren 12,5?

Symptoms of a serious hypersensitivity (allergic) reaction may include a skin rash, mucosal lesions (sores in the mouth or eyes), or swelling of the face, lips, or throat. Official safety guidance indicates that the medicine should be discontinued if any signs of hypersensitivity appear.

Q: Is it acceptable to take Voltaren 12,5 at the same time as paracetamol (acetaminophen)?

Official patient guidance indicates that diclofenac is generally safe to take with paracetamol (also known as acetaminophen). However, verifying information on combining any medicine with a healthcare professional is always recommended.

Q: Are there specific foods or supplements that should be avoided when taking Voltaren 12,5?

The official product information focuses on drug-to-drug and alcohol interactions. Official patient guidance notes there is often limited data on the safety of combining diclofenac with complementary medicines, herbal remedies, or supplements.

Q: Is the 12.5 mg dosage strength of Voltaren associated with a lower risk of side effects?

Official regulatory guidance emphasizes a general principle for all NSAIDs: undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms.

Q: Can Voltaren 12,5 be taken safely without food, or must it be taken with a meal?

This medicine is a suppository intended for rectal administration only, not oral intake. Therefore, the official instructions for use do not include requirements related to taking it with or without food.

Storage Conditions and Requirements

Official regulatory labeling dictates strict conditions for storing Voltaren 12,5 mg Suppositories (Diclofenac) to maintain product integrity and safety.

Storage Requirement	Official Condition
Temperature	Store at or below 30 C (or 25 C regionally).
Protection	Store in the original package to protect from moisture and light.
Stability	Do not use the medicine after the labeled expiry date (shelf-life is typically two years).
Child Safety	Keep out of the sight and reach of children at all times.

---

Disposal Instructions

Proper disposal is required to prevent environmental contamination and misuse.

Unused or expired Voltaren 12.5 mg suppositories must not be thrown away via household waste or wastewater (flushed down the toilet). Dispose of the medicine strictly according to local regulations, typically by returning it to a pharmacist or designated collection point.